Clinical Trial Update: Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial (VICTORY) evaluating rosiglitazone for vein-related coronary atherosclerosis after bypass surgery in patients with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Laval University | Conditions: Diabetes, Coronary Artery Bypass Grafting | Phase 3 | Status: COMPLETED